XML 56 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations (Tables)
12 Months Ended
Dec. 31, 2011
Allocation of Purchase Price to Net Assets of Cellu Tissue Based On Estimates of Fair Value of Assets and Liabilities

We allocated the purchase price to the net assets of Cellu Tissue acquired in the acquisition based on our estimates of the fair value of assets and liabilities as follows:

 

(In thousands)        Amount   

Current assets

     $ 128,079   

Property, plant and equipment

       276,499   

Goodwill

       229,533   

Intangibles

       56,400   

Other assets

       1,500   

 

 

Assets acquired

       692,011   

 

 

Current liabilities

       97,071   

Long-term debt, less current portion

       287,002   

Deferred income taxes

       60,221   

Other liabilities

       732   

 

 

Liabilities assumed

       445,026   

 

 

Net assets acquired

     $ 246,985   

 

 
Unaudited Pro Forma Financial Information
The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had Cellu Tissue been combined with us as of the beginning of 2009.
(In thousands; Unaudited)    2010      2009  

Pro forma net sales

   $  1,902,579       $ 1,761,350   

Pro forma net earnings

     88,713         191,514